SCHEMBL6957178

SCHEMBL6957178

O=C(O)N1C(=S)OCC1c1ccc(F)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.34
RIPK1 Q13546 4/20 0.34
FFAR2 O15552 1/20 0.34
KDM1A O60341 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MTOR P42345 2/20 0.32
TSHR P16473 1/20 0.32
SLC6A9 P48067 2/20 0.32
USP5 P45974 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
EDNRB P24530 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6227914 0.84 MTOR (0.37) HTR7FFAR2KDM1AALDH1A1GAA
SCHEMBL5660885 0.84 MTOR (0.37) HTR7FFAR2KDM1AALDH1A1GAA
SCHEMBL6082708 0.84 MTOR (0.37) HTR7FFAR2KDM1AALDH1A1GAA
SCHEMBL7841196 0.77 TSHR (0.36) HTR7FFAR2KDM1ATSHRSLC6A9
SCHEMBL6955857 0.75 HTR7 (0.34) HTR7RIPK1FFAR2KDM1ATSHR
SCHEMBL6966417 0.73 MTOR (0.39) HTR7ALDH1A1GAAHTTHPGD
SCHEMBL8005453 0.70 ALDH1A1 (0.32) ALDH1A1GAAHTTNPC1LMNA
SCHEMBL5660976 0.70 ALDH1A1 (0.32) ALDH1A1GAAHTTNPC1LMNA
SCHEMBL7599925 0.69 CCNC (0.40) FFAR2TSHRSLC6A9SCD5
SCHEMBL5658978 0.68 NAAA (0.40) NPC1LMNATP53HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620815-B1 Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction SYNAPTIC PHARMACEUTICAL CORPORATION 2003-09-16 US disclosed
EP-0988295-A4 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMA CORP (US) 2003-08-13 EP disclosed
US-6159990-A Oxazolidinones as α1A receptor antagonists SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-12-12 US disclosed
EP-0988295-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-03-29 EP disclosed
WO-1998057940-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-12-23 WO disclosed